Easdaq will today launch trading in four stocks from its arch rival EuroNM, the first time it has directly targeted trading volumes in other European markets as part of its aim to become the first pan-European stock market.

The first four stocks from EuroNM are all biotech stocks, which had a combined trading volume of €780m in February this year.